OSR Health, Inc. (NASDAQ: OSRH) is a healthcare-focused holding company committed to building long-term shareholder value through strategic investment in immuno-oncology, regenerative biologics, and medical device technologies.

Latest Research

https://emerginggrowth.com/profile/osrh/

July 2, 2026: Planning to Reward Long-Term Shareholders - We are bullish with a Buy-Emerging rating and $10.00 target.

May 5, 2026: Specialty-Financed Licensing Deal Delivers Strong De-Risking - We are bullish with a Buy-Emerging rating and $10.00 target.

March 26, 2026: 2nd Materially Positive Event in Recent Months - We remain bullish with a Buy-Emerging rating and a $10.00 price target.

December 4, 2025: New Licensing Deal is a BIG Deal - We remain bullish with a Buy-Emerging rating and a $10.00 price target (on watch for potential upgrade).

October 20, 2025: Future Focus - Initiate coverage with a Buy-Emerging rating with a $10.00 price target. October 20, 2025.

Latest News